Instituto Rosenbusch (BUE:ROSE) Beginning Cash Position: ARS1,219 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:ROSE Instituto Rosenbusch SA BUE:ROSE
42 GF Score
Price ARS162.00
GF Value ARS62.77
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Instituto Rosenbusch Beginning Cash Position?

Instituto Rosenbusch BUE:ROSE +0.62% 42 Beginning Cash Position is ARS1,219 Mil as of Dec. 2025. GuruFocus rates BUE:ROSE with a GF Score™ of 42/100 and a GF Value™ of ARS62.77 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Instituto Rosenbusch's Beginning Cash Position for the quarter that ended in Dec. 2025 was ARS1,219 Mil.

Instituto Rosenbusch's quarterly Beginning Cash Position increased from Jun. 2025 (ARS911 Mil) to Sep. 2025 (ARS1,052 Mil) and increased from Sep. 2025 (ARS1,052 Mil) to Dec. 2025 (ARS1,219 Mil).

Instituto Rosenbusch's annual Beginning Cash Position increased from Dec. 2023 (ARS723 Mil) to Dec. 2024 (ARS1,119 Mil) and increased from Dec. 2024 (ARS1,119 Mil) to Dec. 2025 (ARS1,154 Mil).

Instituto Rosenbusch Beginning Cash Position Related Terms

Instituto Rosenbusch Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Instituto Rosenbusch's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instituto Rosenbusch Beginning Cash Position Chart

Instituto Rosenbusch Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.85 345.50 722.86 1,119.45 1,153.84

Instituto Rosenbusch Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 784.18 952.28 911.02 1,052.10 1,219.33
BUE:ROSE
42GF Score
Instituto Rosenbusch SA BUE:ROSE
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Instituto Rosenbusch Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ARS1,219 Mil mean?
Instituto Rosenbusch (BUE:ROSE) has a Beginning Cash Position of ARS1,219 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Instituto Rosenbusch and its competitors.
Is Instituto Rosenbusch's Beginning Cash Position too high?
Instituto Rosenbusch's current Beginning Cash Position is ARS1,219 Mil. Overall, Instituto Rosenbusch has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's Beginning Cash Position compare to ZTS and UTHR?
Instituto Rosenbusch's Beginning Cash Position of ARS1,219 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Instituto Rosenbusch and its competitors. Instituto Rosenbusch's current Beginning Cash Position is ARS1,219 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS62.77, compared to a current price of ARS162.00 — trading 158.1% above its estimated fair value. The current Beginning Cash Position is ARS1,219 Mil. Instituto Rosenbusch's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current Beginning Cash Position is ARS1,219 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?

Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued. The current stock price of ARS162.00 is trading 158.1% above its estimated GF Value™ of ARS62.77. GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.

Key valuation signals for BUE:ROSE:

  • Beginning Cash Position: ARS1,219 Mil
  • GF Value™: ARS62.77 vs. price of ARS162.00 (158.1% above fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Instituto Rosenbusch Business Description

Address Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
42GF Score

Get the complete analysis for BUE:ROSE

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS162.00
Price
ARS62.77
GF Value